Managment of advanced prostate cancer
26 Jul 2017
Managment of advanced prostate cancer
Precision medicine: a nurses perspective
Identifying rare mutations in lung cancer
Lymphoma highlights from ASCO annual meeting 2017
New trial results and updates on CML, CLL and MDS
Targeting EGFR and ALK mutations
Abiraterone for metastatic, hormone sensitive, prostate cancer
New treatments for acute myeloid leukaemia and lymphoid leukaemia
New drug advancements presented at ASCO
Developing technologies and the field of oncology
The Bonnie J Addario Lung Cancer Foundation
Changing the standard of care: Metastatic prostate cancer